Showing all 11 results

  • Placeholder
    In Stock

    Nitrofurantoin Tablets

    Free

    A Nitrofurantoin tablet is an antibiotic specifically used to treat and prevent urinary tract infections (UTIs), such as cystitis. It works by damaging the DNA of bacteria in the urinary tract.

  • Placeholder
    In Stock

    Nitrofurantoin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Dual-Release Capsule or Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the nitrofuran compounds.

    Active IngredientStrengthPrimary Clinical Function
    Nitrofurantoin (Macrocrystals) USP/Ph.Eur.50 mgProphylactic / Pediatric Standard: Base therapeutic unit for long-term prevention of recurrent UTIs and pediatric dosing.
    Nitrofurantoin (Macrocrystals 25mg + Monohydrate 75mg) USP100 mgGlobal Acute UTI Standard: Premium dual-release adult maintenance dose for the rapid eradication of acute uncomplicated cystitis.
    ExcipientsCarbomer 934P / Povidone K30 / Sugar Spheres / Talc / Magnesium Stearate / Titanium DioxideHydrophilic Polymer Matrix / Binder / Core Substrate / Glidant (Engineered specifically to form a viscous gel upon swallowing, pacing the gastric release perfectly to prevent nausea while ensuring maximum urinary concentration)

    *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict 5-to-7 day acute urology dispensing regimens).

  • Placeholder
    In Stock

    Oxybutynin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.

    Active IngredientStrengthPrimary Clinical Function
    Oxybutynin Chloride USP/Ph.Eur.5 mg (ER)Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy.
    Oxybutynin Chloride USP/Ph.Eur.10 mg / 15 mg (ER)Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity.
    ExcipientsHypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium DioxideHydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate)

    *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).

  • Placeholder
    In Stock

    Phenazopyridine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant PVC/PVDC or Alu-PVC blister strips to ensure the stability of the active dye compound.

    Active IngredientStrengthPrimary Clinical Function
    Phenazopyridine Hydrochloride USP/Ph.Eur.100 mgStandard OTC/Initiation dose for mild-to-moderate urinary tract discomfort.
    Phenazopyridine Hydrochloride USP/Ph.Eur.200 mgGlobal Prescription Standard: Maximum adult dose for severe dysuria and post-operative catheter trauma.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Magnesium StearateDiluent / Superdisintegrant (Engineered for rapid gastric dissolution and swift renal clearance)
  • Placeholder
    In Stock

    Phenazopyridine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.

    Active IngredientStrengthPrimary Clinical Function
    Phenazopyridine HCl USP/Ph.Eur.100 mgOTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief.
    Phenazopyridine HCl USP/Ph.Eur.200 mgPrescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma.
    ExcipientsMicrocrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax CoatingDiluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).

  • Placeholder
    In Stock

    Prulifloxacin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the ester prodrug.

    Active IngredientStrengthPrimary Clinical Function
    Prulifloxacin INN/Ph.Eur.600 mgGlobal Clinical Standard: Maximum adult daily dose for the rapid eradication of susceptible UTI and RTI pathogens.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate / HypromelloseDiluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered for immediate gastric dissolution and synchronized prodrug absorption)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-10 day acute urology and respiratory infection dispensing regimens).

  • Placeholder
    In Stock

    Silodosin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Silodosin INN/Ph.Eur.8 mgGlobal Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH.
    ExcipientsMannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium DioxideDiluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).

  • Placeholder
    In Stock

    Solifenacin Succinate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.

    Active IngredientStrengthPrimary Clinical Function
    Solifenacin Succinate USP/Ph.Eur.5 mgGlobal Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment.
    Solifenacin Succinate USP/Ph.Eur.10 mgHigh-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency.
    ExcipientsLactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / MacrogolDiluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection)
  • Placeholder
    In Stock

    Tamsulosin & Dutasteride Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.

    Active IngredientStrengthPrimary Clinical Function
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release)Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief.
    Dutasteride USP/Ph.Eur.0.5 mgDual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction.
    ExcipientsHypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium StearateSR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation)
  • Placeholder
    In Stock

    Tamsulosin & Finasteride Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.

    Active IngredientStrengthPrimary Clinical Function
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release)Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief.
    Finasteride USP/Ph.Eur.5 mgTargeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage.
    ExcipientsHypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium StearateSR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation)
  • Placeholder
    In Stock

    Tamsulosin Tablets 

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Gel-Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic polymers.

    Active IngredientStrengthPrimary Clinical Use
    Tamsulosin Hydrochloride USP/Ph.Eur.0.4 mg (Modified-Release Tablet)Premium Global Standard: Target once-daily, food-independent adult dose for BPH.
    ExcipientsMacrogol (Polyethylene Glycol) / Magnesium Stearate / Hypromellose / Iron OxideAdvanced Non-Ionic Gel Matrix / Lubricant / Film Coat (Engineered for strict 24-hour continuous diffusion)